A Study Of Coccidioides Species Antigen Detection Assay From Urine Specimens

Overview

About this study

The purpose of this study is to collect urine samples from patients confirmed to be infected with Coccidioides by culture and/or PCR testing of any source.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Any patient with a positive culture or PCR result for Coccidioides species
Urine can be provided within 2 weeks of initiation of antifungal treatment for Coccidioides infection
>2 uL of residual urine collected for routine clinical care

Exclusion Criteria:

Negative culture or PCR result for Coccidioides species; urine provided >2 weeks after antifungal treatment initiation

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 04/27/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Elitza Theel, Ph.D.	Open for enrollment
Rochester, Minn. Mayo Clinic principal investigator Elitza Theel, Ph.D.	Open for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Elitza Theel, Ph.D.

Open for enrollment

Rochester, Minn.

Mayo Clinic principal investigator

Elitza Theel, Ph.D.

Open for enrollment

More information

Publications

Publications are currently not available

Clinical Trials